CXCR4 Knockdown Via CRISPR/CAS9 in a Tumor-Associated Macrophage Model Decreases Human Breast Cancer Cell Migration

Luis Jaramillo-Valverde1,2, Kelly S Levano1, Silvia Capristano1

  • 1Biotechnology and Molecular Biology Laboratory, Instituto Nacional de Salud, Lima, PER.

Cureus
|February 3, 2022
PubMed

Insights

Tumor-associated macrophages (TAMs) influence breast cancer metastasis. Targeting the CXCR4 receptor on TAMs can reduce breast cancer cell migration, offering new therapeutic strategies.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Breast cancer metastasis is a leading cause of death, driven by the tumor microenvironment.
  • Tumor-associated macrophages (TAMs) are key immune cells in this microenvironment, influencing tumor cell migration.
  • The CXCR4 receptor and its ligand CXCL12 are critical for tumor progression and survival, with CXCR4 expressed on both TAMs and cancer cells.

Purpose of the Study:

  • To investigate the role of CXCR4 expressed specifically on TAMs in breast cancer cell migration.
  • To understand the crosstalk between TAMs and breast cancer cells mediated by CXCR4.

Main Methods:

  • Differentiated THP-1 cells were used as a model for TAMs.
  • CRISPR-Cas9 gene editing was employed to reduce CXCR4 expression in these TAM models.
  • MCF7 breast cancer cells were co-cultured with genetically edited and unedited TAM models.
  • Wound healing migration assays were performed to assess cancer cell migration rates.

Main Results:

  • Co-culture with CXCR4-edited TAMs significantly reduced the migration rate of MCF7 breast cancer cells compared to controls.
  • This indicates that CXCR4 on TAMs plays a crucial role in promoting breast cancer cell migration.

Conclusions:

  • The study highlights the significant role of CXCR4 expressed on TAMs in facilitating breast cancer cell migration.
  • Targeting the TAM-CXCR4 axis represents a potential therapeutic strategy to inhibit breast cancer metastasis.

Related Concept Videos